Patent details

91036 Product Name: Adefovir dipivoxil et ses dérivés pharmaceutiquement acceptables (Hepsera®)

Basic Information

Publication number:
91036
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP911153120
Legal Status:
Expired
Application number:
91036
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/03/251/001
Marketing Authorization Type:
Marketing Authorization Date:
06/03/2003
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
13/08/2003
First Marketing Authorization date:
06/03/2003
Grant date:
13/10/2003
Activation date:
10/09/2011
Publication date:
13/10/2003
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
10/09/2016
SPC Extension Expiration:
10/09/2016
Rejection date:
Withdrawal date:

Owner

From:
13/08/2003
 
 

Name:
INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC
Address:
FLEMINGOVO NAMESTI 2, 166 10, PRAHA 6 DEJVICE, Unknown (UNKNOWN)

Name:
Rega Stichting Vzw.
Address:
Minderbroedersstraat 10, B- 3000 Leuven, Belgium (BE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
13/08/2003
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Tortolani David R.
Address:
United States (US)

2

Name:
Martin John C.
Address:
United States (US)

3

Name:
Bronson Joanne J.
Address:
United States (US)

4

Name:
Mansuri Muzammil M.
Address:
United States (US)

5

Name:
Starrett Jr. John E.
Address:
United States (US)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
26/08/2015
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages